Low incidence of paradoxical reductions in HDL-C levels in dyslipidemic patients treated with fenofibrate alone or in combination with ezetimibe or ezetimibe/simvastatin.
Lipids Health Dis
; 10: 212, 2011 Nov 16.
Article
em En
| MEDLINE
| ID: mdl-22087637
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Fenofibrato
/
Azetidinas
/
Sinvastatina
/
Dislipidemias
/
HDL-Colesterol
/
Anticolesterolemiantes
Tipo de estudo:
Clinical_trials
/
Incidence_studies
/
Risk_factors_studies
Limite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2011
Tipo de documento:
Article